Tumor budding or tumor baloney?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. A Novel Superpixel Approach to the Tumoral Microenvironment in Colorectal Cancer.Journal of pathology informatics · 2022
   Article
2. Superpixel image segmentation of VISTA expression in colorectal cancer and its relationship to the tumoral microenvironment.Scientific reports · 2021
   Article
3. Understanding the role of indoleamine-2,3-dioxygenase and stromal differentiation in rare subtype endometrial cancer.Rare tumors · 2021
   Article

Corrections and comments

• Comment on
  Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as